{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T21:00:33Z","timestamp":1790283633818,"version":"4.1.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"16","license":[{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,8,22]],"date-time":"2017-08-22T00:00:00Z","timestamp":1503360000000},"content-version":"vor","delay-in-days":386,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Cardiovascular Interventions"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1016\/j.jcin.2016.06.008","type":"journal-article","created":{"date-parts":[[2016,8,15]],"date-time":"2016-08-15T14:30:42Z","timestamp":1471271442000},"page":"1731-1742","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":94,"title":["Drug-Coated Balloon Versus Plain Balloon\u00a0Angioplasty for the Treatment of\u00a0Femoropopliteal Artery Disease"],"prefix":"10.1016","volume":"9","author":[{"given":"Daniele","family":"Giacoppo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Cassese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukinori","family":"Harada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roisin","family":"Colleran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Michel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimiliano","family":"Fusaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adnan","family":"Kastrati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Byrne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcin.2016.06.008_bib1","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1093\/eurheartj\/ehr211","article-title":"ESC\u00a0Guidelines on the diagnosis and treatment of\u00a0peripheral artery diseases: document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries","volume":"32","author":"Tendera","year":"2011","journal-title":"Eur Heart J"},{"issue":"Suppl 1","key":"10.1016\/j.jcin.2016.06.008_bib2","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.ejvs.2006.09.024","article-title":"Inter\u2013Society Consensus for the Management of Peripheral Arterial Disease (TASC II)","volume":"33","author":"Norgren","year":"2007","journal-title":"Eur J Vasc Endovasc Surgery"},{"key":"10.1016\/j.jcin.2016.06.008_bib3","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1056\/NEJMoa051303","article-title":"Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery","volume":"354","author":"Schillinger","year":"2006","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jcin.2016.06.008_bib4","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1161\/CIRCULATIONAHA.107.689141","article-title":"Nitinol stent implantation versus percutaneous transluminal angioplasty in superficial femoral artery lesions up to 10 cm in length: the femoral artery stenting trial (FAST)","volume":"116","author":"Krankenberg","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.jcin.2016.06.008_bib5","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1016\/j.jacc.2013.03.034","article-title":"Sustained safety and effectiveness of paclitaxel\u2013eluting stents for femoropopliteal lesions: 2\u2013year follow\u2013up from the Zilver PTX randomized and single\u2013arm clinical studies","volume":"61","author":"Dake","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2016.06.008_bib6","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJMoa1406235","article-title":"Trial of a paclitaxel\u2013coated balloon for femoropopliteal artery disease","volume":"373","author":"Rosenfield","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jcin.2016.06.008_bib7","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1056\/NEJMoa0706356","article-title":"Local delivery of paclitaxel to inhibit restenosis during angioplasty of the leg","volume":"358","author":"Tepe","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jcin.2016.06.008_bib8","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1161\/CIRCULATIONAHA.115.017364","article-title":"Drug\u2013coated balloon versus standard balloon for superficial femoral artery in\u2013stent restenosis: the Randomized Femoral Artery In\u2013Stent Restenosis (FAIR) Trial","volume":"132","author":"Krankenberg","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.jcin.2016.06.008_bib9","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/nrcardio.2013.165","article-title":"Drug\u2013coated balloon therapy in coronary and peripheral artery disease","volume":"11","author":"Byrne","year":"2014","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.jcin.2016.06.008_bib10","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1161\/CIRCINTERVENTIONS.112.969972","article-title":"Paclitaxel\u2013coated versus uncoated balloon angioplasty reduces target lesion revascularization in patients with femoropopliteal arterial disease: a meta\u2013analysis of randomized trials","volume":"5","author":"Cassese","year":"2012","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.jcin.2016.06.008_bib11","doi-asserted-by":"crossref","first-page":"4002","DOI":"10.1016\/j.ijcard.2013.06.081","article-title":"Paclitaxel\u2013coated balloon or primary bare nitinol stent for revascularization of femoropopliteal artery: a meta\u2013analysis of randomized trials versus uncoated balloon and an adjusted indirect comparison","volume":"168","author":"Fusaro","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jcin.2016.06.008_bib12","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/j.jvs.2014.01.041","article-title":"Bayesian network meta\u2013analysis of nitinol stents, covered stents, drug\u2013eluting stents, and drug\u2013coated balloons in the femoropopliteal artery","volume":"59","author":"Katsanos","year":"2014","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jcin.2016.06.008_bib13","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1093\/eurheartj\/ehv204","article-title":"Drug-coated balloon treatment for lower extremity vascular disease intervention: an international positioning document","volume":"37","author":"Cortese","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jcin.2016.06.008_bib14","doi-asserted-by":"crossref","first-page":"b2700","DOI":"10.1136\/bmj.b2700","article-title":"The PRISMA statement for reporting systematic reviews and meta\u2013analyses of studies that evaluate healthcare interventions: explanation and elaboration","volume":"339","author":"Liberati","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.jcin.2016.06.008_bib15","unstructured":"Higgins JPT, Green S. Cochrane handbook for systematic reviews of interventions 5.1.0 [Updated March 2011]. Available at: www.cochrane\u2013handbook.org. 2011. Accessed December 10,\u00a02015."},{"key":"10.1016\/j.jcin.2016.06.008_bib16","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta\u2013analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Control Clin Trials"},{"key":"10.1016\/j.jcin.2016.06.008_bib17","series-title":"Introduction to meta\u2013analysis","author":"Borenstein","year":"2009"},{"key":"10.1016\/j.jcin.2016.06.008_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2202\/1557-4679.1168","article-title":"Mixed\u2013effects Poisson regression models for meta\u2013analysis of follow\u2013up studies with constant or varying durations","volume":"5","author":"Bagos","year":"2009","journal-title":"Int J Biostat"},{"key":"10.1016\/j.jcin.2016.06.008_bib19","series-title":"Bayesian approaches to clinical trials and health\u2013care evaluation. Statistics in practice","author":"Spiegelhalter","year":"2004"},{"key":"10.1016\/j.jcin.2016.06.008_bib20","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1177\/0272989X13487257","article-title":"Evidence synthesis for decision making 6: embedding evidence synthesis in probabilistic cost\u2013effectiveness analysis","volume":"33","author":"Dias","year":"2013","journal-title":"Med Decis Making"},{"key":"10.1016\/j.jcin.2016.06.008_bib21","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1002\/sim.2112","article-title":"How vague is vague? A simulation study of the impact of the use of vague prior distributions in MCMC using WinBUGS","volume":"24","author":"Lambert","year":"2005","journal-title":"Stat Med"},{"key":"10.1016\/j.jcin.2016.06.008_bib22","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1080\/10618600.1998.10474787","article-title":"General methods for monitoring convergence of iterative simulations","volume":"7","author":"Brooks","year":"1998","journal-title":"J\u00a0Comput Graph Stat"},{"key":"10.1016\/j.jcin.2016.06.008_bib23","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jclinepi.2007.03.013","article-title":"Trial sequential analysis may establish when firm evidence is reached in cumulative meta\u2013analysis","volume":"61","author":"Wetterslev","year":"2008","journal-title":"J\u00a0Clin Epidemiol"},{"key":"10.1016\/j.jcin.2016.06.008_bib24","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/1471-2288-9-86","article-title":"Estimating required information size by quantifying diversity in random\u2013effects model meta\u2013analyses","volume":"9","author":"Wetterslev","year":"2009","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.jcin.2016.06.008_bib25","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1177\/1526602814564383","article-title":"Paclitaxel\u2013releasing balloon in femoropopliteal lesions using a BTHC excipient: twelve\u2013month results from the BIOLUX P\u2013I randomized trial","volume":"22","author":"Scheinert","year":"2015","journal-title":"J\u00a0Endovasc Ther"},{"key":"10.1016\/j.jcin.2016.06.008_bib26","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1161\/CIRCULATIONAHA.107.735985","article-title":"Inhibition of restenosis in femoropopliteal arteries: paclitaxel\u2013coated versus uncoated balloon: femoral paclitaxel randomized pilot trial","volume":"118","author":"Werk","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.jcin.2016.06.008_bib27","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1161\/CIRCULATIONAHA.114.011004","article-title":"Drug\u2013coated balloon versus standard percutaneous transluminal angioplasty for the treatment of superficial femoral and popliteal peripheral artery disease: 12\u2013month results from the IN.PACT SFA randomized trial","volume":"131","author":"Tepe","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.jcin.2016.06.008_bib28","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jcin.2013.05.022","article-title":"The LEVANT I (Lutonix paclitaxel\u2013coated balloon for the prevention of femoropopliteal restenosis) trial for femoropopliteal revascularization: first\u2013in\u2013human\u00a0randomized trial of low\u2013dose drug\u2013coated balloon versus uncoated balloon angioplasty","volume":"7","author":"Scheinert","year":"2014","journal-title":"J\u00a0Am Coll Cardiol Intv"},{"key":"10.1016\/j.jcin.2016.06.008_bib29","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1161\/CIRCINTERVENTIONS.112.971630","article-title":"Paclitaxel\u2013coated balloons reduce restenosis after femoro\u2013popliteal angioplasty: evidence from the randomized PACIFIER trial","volume":"5","author":"Werk","year":"2012","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.jcin.2016.06.008_bib30","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1016\/j.jacc.2015.09.063","article-title":"Durability of treatment effect using a drug\u2013coated balloon for femoropopliteal lesions: 24\u2013month results of IN.PACT SFA","volume":"66","author":"Laird","year":"2015","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2016.06.008_bib31","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jcin.2014.07.023","article-title":"Angioplasty of femoral\u2013popliteal arteries with drug\u2013coated balloons: 5\u2013year follow\u2013up of the THUNDER trial","volume":"8","author":"Tepe","year":"2015","journal-title":"J Am Coll Cardiol Intv"},{"key":"10.1016\/j.jcin.2016.06.008_bib32","first-page":"624","article-title":"Two-year results and subgroup analyses of the PEPCAD China in-stent restenosis trial: a prospective, multicenter, randomized trial for the treatment of drug-eluting stent in-stent restenosis","volume":"87","author":"Xu","year":"2016","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.jcin.2016.06.008_bib33","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.jcin.2015.01.031","article-title":"Long\u2013Term efficacy and safety of paclitaxel\u2013eluting balloon for the treatment of drug\u2013eluting stent restenosis: 3\u2013year results of a randomized controlled trial","volume":"8","author":"Kufner","year":"2015","journal-title":"J Am Coll Cardiol Intv"},{"key":"10.1016\/j.jcin.2016.06.008_bib34","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1161\/CIRCINTERVENTIONS.111.962324","article-title":"Paclitaxel\u2013eluting stents show superiority to balloon angioplasty and bare metal stents in femoropopliteal disease: twelve\u2013month Zilver PTX randomized study results","volume":"4","author":"Dake","year":"2011","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.jcin.2016.06.008_bib35","doi-asserted-by":"crossref","first-page":"d4002","DOI":"10.1136\/bmj.d4002","article-title":"Recommendations for examining and interpreting funnel plot asymmetry in meta\u2013analyses of randomised controlled trials","volume":"343","author":"Sterne","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.jcin.2016.06.008_bib36","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/RLI.0b013e31820577df","article-title":"Dose response to Paclitaxel-coated balloon catheters in the porcine coronary overstretch and stent implantation model","volume":"46","author":"Kelsch","year":"2011","journal-title":"Invest Radiol"},{"key":"10.1016\/j.jcin.2016.06.008_bib37","doi-asserted-by":"crossref","first-page":"730","DOI":"10.4244\/EIJV7I6A116","article-title":"Vascular effects of paclitaxel following drug-eluting balloon angioplasty in a porcine coronary model: the importance of excipients","volume":"7","author":"Radke","year":"2011","journal-title":"EuroIntervention"},{"key":"10.1016\/j.jcin.2016.06.008_bib38","first-page":"132","article-title":"Vascular, downstream, and pharmacokinetic responses to treatment with a low dose drug-coated balloon in a swine femoral artery model","volume":"83","author":"Yazdani","year":"2014","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.jcin.2016.06.008_bib39","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1002\/sim.1187","article-title":"How should meta\u2013regression analyses be undertaken and interpreted?","volume":"21","author":"Thompson","year":"2002","journal-title":"Stat Med"}],"container-title":["JACC: Cardiovascular Interventions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936879816308305?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936879816308305?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T18:04:09Z","timestamp":1761847449000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1936879816308305"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":39,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2016,8]]}},"alternative-id":["S1936879816308305"],"URL":"https:\/\/doi.org\/10.1016\/j.jcin.2016.06.008","relation":{},"ISSN":["1936-8798"],"issn-type":[{"value":"1936-8798","type":"print"}],"subject":[],"published":{"date-parts":[[2016,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Drug-Coated Balloon Versus Plain Balloon\u00a0Angioplasty for the Treatment of\u00a0Femoropopliteal Artery Disease","name":"articletitle","label":"Article Title"},{"value":"JACC: Cardiovascular Interventions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcin.2016.06.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 by the American College of Cardiology Foundation. Published by Elsevier","name":"copyright","label":"Copyright"}]}}